Valley Brook Capital Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Hold
425
0.13% 108
2026
Q1
$239K Hold
425
0.16% 101
2025
Q4
$288K Hold
425
0.19% 98
2025
Q3
$272K Hold
425
0.18% 95
2025
Q2
$228K Buy
+425
New +$203K 0.17% 101
2024
Q4
Sell
-740
Closed -$374K 116
2024
Q3
$374K Buy
740
+10
+1% +$4.86K 0.27% 84
2024
Q2
$356K Buy
730
+10
+1% +$5.02K 0.28% 79
2024
Q1
$389K Buy
720
+20
+3% +$10.9K 0.31% 77
2023
Q4
$389K Sell
700
-50
-7% -$23.5K 0.34% 73
2023
Q3
$328K Sell
750
-125
-14% -$62.3K 0.32% 78
2023
Q2
$439K Buy
875
+25
+3% +$12K 0.41% 63
2023
Q1
$425K Buy
850
+85
+11% +$40.7K 0.39% 67
2022
Q4
$312K Buy
765
+10
+1% +$3.88K 0.3% 79
2022
Q3
$245K Buy
755
+65
+9% +$23.9K 0.27% 88
2022
Q2
$242K Buy
690
+100
+17% +$40.8K 0.25% 90
2022
Q1
$322K Buy
590
+15
+3% +$7.89K 0.28% 83
2021
Q4
$378K Buy
575
+50
+10% +$31.4K 0.33% 75
2021
Q3
$326K Hold
525
0.32% 76
2021
Q2
$331K Buy
525
+75
+17% +$41.4K 0.32% 81
2021
Q1
$220K Buy
450
+15
+3% +$7.51K 0.2% 98
2020
Q4
$217K Buy
+435
New +$195K 0.21% 95

Other funds holding IDXX

Valley Brook Capital Group's IDXX Position: Q2 2026 in Review

Valley Brook Capital Group held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 425 shares worth $224K. The position accounts for 0.13% of the portfolio, ranked #108.

Valley Brook Capital Group first reported a position in IDXX in Q4 2020 and has held it in 21 quarters since. The position peaked at $439K in Q2 2023. 658 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Valley Brook Capital Group held 425 shares of Idexx Laboratories worth $224K as of Q2 2026.
  • Valley Brook Capital Group left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.13% of Valley Brook Capital Group's portfolio in Q2 2026, its #108 holding.
  • Valley Brook Capital Group first reported a position in Idexx Laboratories in Q4 2020 and has held it in 21 quarters since.
  • Valley Brook Capital Group's Idexx Laboratories position peaked at $439K in Q2 2023.
  • 658 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.